Please assess the completion status of the following clinical trial:

Trial Title: Long-Term Treatment With rhIGF-1 in GHIS

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Height \<-2SD for age and gender~* IGF-1 \<-2SD for age and gender~* Evidence of GH resistance~Exclusion Criteria:~* closed epiphyses~* prior active malignancy~* major organ disfunction~* treatment with medications that would diminish growth~* clinically significant cardiac abnormalities

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 21 Years
- Healthy Volunteers: f

Study Arms:
- mecasermin, injections BID of rhIGF-1 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).